An Insight into the Pathogenesis, Diagnosis and Treatment of SARS-Cov-2 with a Synopsis of Situation in Malaysia during the 2020 Outbreak
DOI:
https://doi.org/10.47430/ujmr.2162.002Keywords:
diagnosis,, Malaysia,, pathogenesis,, Sars-CoV-2,, COVID-19,, treatment.Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the novel coronavirus (CoV) that emerged from China causing diseases known as COVID-19, mainly involves the respiratory system. It has ravaged through most of the world causing death in huge numbers. CoVs are zoonotic as they are transferred from animals to humans. Several animals have been suggested to be the host for SARS-CoV-2 ranging from bats, camels and pigs. The presence of a type 1 transmembrane glycoprotein called spike protein is responsible for CoVs’ ability to penetrate the host’s tissues. The immune response elicited during the proliferation of SARS-CoV-2 is most largely dependent on the macrophages, dendritic cells, T-cells and the human epithelial cells which determine the aftermath and lodging of chemokines and cytokines. The RT-qPCR is the preferred test for the confirmation of the disease although several Rapid Diagnostic Tests are also in use. Remdesivir, favilavir, niclosamide and ciclesonide are promising drugs under clinical trial or research to manage COVID-19. Several vaccines are also under clinical trial phase to mitigate the effect of COVID-19. Malaysia had its index case on the January 24th, 2020 and since then, Malaysia handling of the pandemic have been superb, well planned out and worthy of emulation from other countries. They have carried out an unprecedented number of tests surpassing any other country in the region.
Downloads
References
Abbasi, J. (2020). The Promise and Peril of Antibody Testing for COVID-19. JAMA - Journal of the American Medical Association. https://doi.org/10.1001/jama.2020.6170
Abdullah, N.H. (2020). Current Status on the Coronavirus Disease 2019 (COVID-19) Situation in Malaysia". From the Desk of the Director-General of Health Malaysia. 2 May 2020. Retrieved 17 May 2020.
Abdullah, N.H. (2020). "Kenyataan Akhbar KPK 6 Januari 2020 – Makluman Kejadian Kejadian Kluster Radang Paru-Paru (Pneumonia) di Wuhan, Republik Rakyat China". From the Desk of the Director-General of Health Malaysia. Retrieved 17 May 2020.
Agostini, M. L., Andres, E. L., Sims, A. C., Graham, R. L., Sheahan, T. P., Lu, X., … Denison, M. R. (2018). Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. MBio, 9(2). https://doi.org/10.1128/mBio.00221-18
Alsaad, K. O., Hajeer, A. H., Al Balwi, M., Al Moaiqel, M., Al Oudah, N., Al Ajlan, A., … Arabi, Y. M. (2018). Histopathology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection - clinicopathological and ultrastructural study. Histopathology, 72(3), 516–524. https://doi.org/10.1111/his.13379
Bustin, S. A. (2005). Real-time, fluorescence-based quantitative PCR: A snapshot of current procedures and preferences. Expert Review of Molecular Diagnostics, Vol. 5, pp. 493–498. https://doi.org/10.1586/14737159.5.4.493
Canton, J., Fehr, A. R., Fernandez-Delgado, R., Gutierrez-Alvarez, F. J., Sanchez-Aparicio, M. T., García-Sastre, A., … Sola, I. (2018). MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection. PLOS Pathogens, 14(1), e1006838. https://doi.org/10.1371/journal.ppat.1006838
Centre for Disease Control (2020). Testing for COVID-19 | CDC. (n.d.). Retrieved May 17, 2020, from https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html
Cong, Y., Hart, B. J., Gross, R., Zhou, H., Frieman, M., Bollinger, L., … Holbrook, M. R. (2018). MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells. PLoS ONE, 13(3). https://doi.org/10.1371/journal.pone.0194868
Damon, W. (2020). "World leaders urge cooperation in vaccine hunt, raise $8 billion". Yahoo Finance. Retrieved 17 May 2020.
Discovery of T-Cell Infection and Apoptosis by Middle East Respiratory Syndrome Coronavirus. (2020). Retrieved May 17, 2020, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760413/
Drosten, C., Seilmaier, M., Corman, V. M., Hartmann, W., Scheible, G., Sack, S., … Wendtner, C. M. (2013). Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. The Lancet Infectious Diseases, 13(9), 745–751. https://doi.org/10.1016/S1473-3099(13)70154-3
Drosten, C. (2020). "Coronavirus-Update Folge 22" (PDF). NDR. Archived (PDF) from the original on 31 March 2020. Retrieved 17 May 2020.
Durai, P., Batool, M., Shah, M., & Choi, S. (2015). Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control. Experimental & Molecular Medicine, Vol. 47, p. e181. https://doi.org/10.1038/emm.2015.76
Fehr, A. R., & Perlman, S. (2015). Coronaviruses: An overview of their replication and pathogenesis. In Coronaviruses: Methods and Protocols (pp. 1–23). https://doi.org/10.1007/978-1-4939-2438-7_1
Food and Drug Administration (2020). "Cellex Emergency Use Authorization". Retrieved 17 May 2020.
Food and Drug Administration (2020). Remdesivir EUA Letter of Authorization (PDF). 1 May 2020. Retrieved 17 May 2020.
Garoff, H., Hewson, R., & Opstelten, D.-J. E. (1998). Virus Maturation by Budding. Microbiology and Molecular Biology Reviews, 62(4), 1171–1190. https://doi.org/10.1128/mmbr.62.4.1171-1190.1998
Global Progress on COVID-19 Serology-Based Testing. (2020). Retrieved May 17, 2020, from https://www.centerforhealthsecurity.org/resources/COVID-19/serology/Serology-based-tests-for-COVID-19.html#sec2
Grenfell, R & Drew, T (2020). "Here's Why It's Taking So Long to Develop a Vaccine for the New Coronavirus". Science Alert. Archived from the original on 28 February 2020. Retrieved 17 May 2020. Available from: https://www.medrxiv.org/content/10.1101/2020.03.17.20037788v1.full.pdf
Hauck, J. (2020). Coronavirus: FDA authorizes Abbott Labs’ 5-minute COVID-19 test. (n.d.). Retrieved May 17, 2020, from https://www.usatoday.com/story/news/health/2020/03/28/coronavirus-fda-authorizes-abbott-labs-fast-portable-covid-test/2932766001/
Holden, M. J., & Wang, L. (2008). Quantitative Real-Time PCR: Fluorescent Probe Options and Issues. In Standardization and Quality Assurance in Fluorescence Measurements II (pp. 489–508). https://doi.org/10.1007/4243_2008_046
Hsu, L. Y., Lee, C. C., Green, J. A., Ang, B., Paton, N. I., Lee, L., … Leo, Y. S. (2003). Severe acute respiratory syndrome (SARS) in Singapore: Clinical features of the index patient and initial contacts. Emerging Infectious Diseases, 9(6), 713–717. https://doi.org/10.3201/eid0906.030264
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
Jeon, S., Ko, M., Lee, J., Choi, I., Byun, S. Y., Park, S., … Kim, S. (2020). Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/AAC.00819-20
Jeong, S. (2020). "Korea approves 2 more COVID-19 detection kits for urgent use". Korea Biomedical Review.
Lau, S. K. P., Lau, C. C. Y., Chan, K. H., Li, C. P. Y., Chen, H., Jin, D. Y., … Yuen, K. Y. (2013). Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: Implications for pathogenesis and treatment. Journal of General Virology, 94(PART 12), 2679–2690. https://doi.org/10.1099/vir.0.055533-0
Lee, E. Y. P., Ng, M. Y., & Khong, P. L. (2020). COVID-19 pneumonia: what has CT taught us? The Lancet Infectious Diseases, Vol. 20, pp. 384–385. https://doi.org/10.1016/S1473-3099(20)30134-1
Li, G., & De Clercq, E. (2020). Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature Reviews. Drug Discovery, Vol. 19, pp. 149–150. https://doi.org/10.1038/d41573-020-00016-0
Mackay, I. M., & Arden, K. E. (2015). MERS coronavirus: diagnostics, epidemiology and transmission. Virology Journal, Vol. 12, pp. 1–21. https://doi.org/10.1186/s12985-015-0439-5
Mallapaty, S. (2020). Will antibody tests for the coronavirus really change everything? Nature. https://doi.org/10.1038/d41586-020-01115-z
Martzy, R., Kolm, C., Krska, R., Mach, R. L., Farnleitner, A. H., & Reischer, G. H. (2019). Challenges and perspectives in the application of isothermal DNA amplification methods for food and water analysis. Analytical and Bioanalytical Chemistry, 411(9), 1695–1702. https://doi.org/10.1007/s00216-018-1553-1
Menachery, V. D., Eisfeld, A. J., Schäfer, A., Josset, L., Sims, A. C., Proll, S., … Baric, R. S. (2014). Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses. MBio, 5(3). https://doi.org/10.1128/mBio.01174-14
Menachery, V. D., Schäfer, A., Burnum-Johnson, K. E., Mitchell, H. D., Eisfeld, A. J., Walters, K. B., … Baric, R. S. (2018). MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape. Proceedings of the National Academy of Sciences of the United States of America, 115(5), E1012–E1021. https://doi.org/10.1073/pnas.1706928115
Minion, R.D. (2020). "Institute For Medical Research Malaysia Begins Testing Local Vaccines To Treat COVID-19". RojakDaily. Archived from the original on 9 April 2020. Retrieved 17 May 2020.
Ong, J. (2020). "Putrajaya gazettes 409 facilities as Covid-19 quarantine stations". The Malay Mail. Archived from the original on 22 March 2020. Retrieved 17 May 2020.
Park, J. E., Li, K., Barlan, A., Fehr, A. R., Perlman, S., McCray, P. B., & Gallagher, T. (2016). Proteolytic processing of middle east respiratory syndrome coronavirus spikes expands virus tropism. Proceedings of the National Academy of Sciences of the United States of America, 113(43), 12262–12267. https://doi.org/10.1073/pnas.1608147113
Paules, C. I., Marston, H. D., & Fauci, A. S. (2020). Coronavirus Infections-More Than Just the Common Cold. JAMA - Journal of the American Medical Association, Vol. 323, pp. 707–708. https://doi.org/10.1001/jama.2020.0757
Public Health of England (2020). PHE novel coronavirus diagnostic test rolled out across UK". GOV.UK. Retrieved 17 May 2020
Pyrc, K., Berkhout, B., & van der Hoek, L. (2007). Identification of new human coronaviruses. Expert Review of Anti-Infective Therapy, 5(2), 245–253. https://doi.org/10.1586/14787210.5.2.245
Rabouw, H. H., Langereis, M. A., Knaap, R. C. M., Dalebout, T. J., Canton, J., Sola, I., … van Kuppeveld, F. J. M. (2016). Middle East Respiratory Coronavirus Accessory Protein 4a Inhibits PKR-Mediated Antiviral Stress Responses. PLoS Pathogens, 12(10). https://doi.org/10.1371/journal.ppat.1005982
Rafidi, R. (2020). "Malaysian varsities join Covid-19 testing battle". New Straits Times. Archived from the original on 9 April 2020. Retrieved 17 May 2020.
Raj, K., Rohit, Ghosh, A., & Singh, S. (2020). Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectives. VirusDisease, p. 1. https://doi.org/10.1007/s13337-020-00580-4
Raj, V. S., Osterhaus, A. D. M. E., Fouchier, R. A. M., & Haagmans, B. L. (2014). MERS: Emergence of a novel human coronavirus. Current Opinion in Virology, Vol. 5, pp. 58–62. https://doi.org/10.1016/j.coviro.2014.01.010
Ratcliff, R. M., Chang, G., Kok, T. W., & Sloots, T. P. (2007). Molecular diagnosis of medical viruses. Current Issues in Molecular Biology, Vol. 9, pp. 87–102. https://doi.org/10.21775/cimb.009.087
Salehi, S., Abedi, A., Balakrishnan, S., & Gholamrezanezhad, A. (2020). Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. AJR. American Journal of Roentgenology, 1–7. https://doi.org/10.2214/AJR.20.23034
Sanjuán, R., & Domingo-Calap, P. (2016). Mechanisms of viral mutation. Cellular and Molecular Life Sciences, Vol. 73, pp. 4433–4448. https://doi.org/10.1007/s00018-016-2299-6
Scavone, C., Brusco, S., Bertini, M., Sportiello, L., Rafaniello, C., Zoccoli, A., … Capuano, A. (2020). Current pharmacological treatments for COVID‐19: what’s next? British Journal of Pharmacology. https://doi.org/10.1111/bph.15072
Sheridan, C. (2020). Coronavirus and the race to distribute reliable diagnostics. Nature Biotechnology, Vol. 38, pp. 382–384. https://doi.org/10.1038/d41587-020-00002-2
Sipalan, J. & Holmes, S. (2020). "Malaysia confirms first cases of coronavirus infection". Reuters. Archived from the original on 18 February 2020. Retrieved 17 May 2020.
Thanh Le, T., Andreadakis, Z., Kumar, A., Gómez Román, R., Tollefsen, S., Saville, M., & Mayhew, S. (2020). The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery. https://doi.org/10.1038/d41573-020-00073-5
To, K. K. W., Hung, I. F. N., Chan, J. F. W., & Yuen, K. Y. (2013). From SARS coronavirus to novel animal and human coronaviruses. Journal of Thoracic Disease, 5(SUPPL.2), S103. https://doi.org/10.3978/j.issn.2072-1439.2013.06.02
Wang, L., Byrum, B., & Zhang, Y. (2014). Detection and genetic characterization of delta coronavirus in pigs, Ohio, USA, 2014. Emerging Infectious Diseases, 20(7), 1227–1230. https://doi.org/10.3201/eid2007.140296
Wern Jun, S. (2020). "Movement control order not a lockdown, says former health minister". The Malay Mail. Archived from the original on 17 March 2020. Retrieved 17 May 2020.
World Health Organization (2020). COVID-19 situation reports. (n.d.). Retrieved May 16, 2020, from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
World Health Organization (2020). WHO lists two COVID-19 tests for emergency use. (n.d.). Retrieved May 17, 2020, from https://www.who.int/news-room/detail/07-04-2020-who-lists-two-covid-19-tests-for-emergency-use
Xia, S., Liu, Q., Wang, Q., Sun, Z., Su, S., Du, L., … Jiang, S. (2014). Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein. Virus Research, 194, 200–210. https://doi.org/10.1016/j.virusres.2014.10.007
Yang, Y., Zhang, L., Geng, H., Deng, Y., Huang, B., Guo, Y., … Tan, W. (2013). The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein and Cell, 4(12), 951–961. https://doi.org/10.1007/s13238-013-3096-8
Zhao, Y., Chen, F., Li, Q., Wang, L., & Fan, C. (2015). Isothermal Amplification of Nucleic Acids. Chemical Reviews, Vol. 115, pp. 12491–12545. https://doi.org/10.1021/acs.chemrev.5b00428
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 UMYU Journal of Microbiology Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
